IVD China last week: Sekisui & Realbio, Thermo Fisher Scientific & Biotree, Predica Diagnostics & MGI, Hugo Biotech & Watchmaker Genomics, Pluslife & Gates Foundation

Sekisui Medical and Realbio Group enter into a strategic partnership

On July 16, 2024, the signing ceremony of the strategic cooperation agreement between nationally renowned IVD company Sekisui Medical Technology(China)Co.,Ltd. and Realbio Group. Realbio Group and Sekisui Medical have entered into strategic cooperation in the areas of collaborative research and development (sample banking services, etc.), joint laboratories, and total supply chain solutions, which will help Sekisui Medical to promote the localized strategic layout of the Chinese market.

Thermo Fisher and Biotree join hands to build a multi-omics platform to promote research innovation and results translation

Recently, Thermo Fisher Scientific and Biotree completed the joint laboratory listing and strategic cooperation signing ceremony. The two sides first signed a cooperation laboratory in 2020. This time, they will work closely together again to build a multi-omics platform integrating high-throughput, high-precision, and cutting-edge applications, and further develop close cooperation in the combination of industry, academia, and research, solution development, and results transformation, so as to jointly promote the development of mass spectrometry multi-omics in the fields of life sciences, pharmaceuticals and healthcare, and modernization of agriculture, and create a new ecology of the technology together.

Dutch oncology diagnostics company Predica Diagnostics enters into collaboration with MGI Tech to develop targeted RNA sequencing technology

On July 11, Predica Diagnostics, a leading innovator in oncology diagnostics, and MGI Tech announced a collaboration to develop Predica's targeted RNA sequencing technology on MGI Tech's high-throughput sequencing platform for precision medicine. The collaboration aims to lead a revolution in molecular diagnostics by enabling early cancer detection and facilitating personalized targeted treatment strategies by combining Predica Diagnostics' advanced sequencing assays with MGI Tech's cutting-edge sequencing platform.

Hugo Biotech and Watchmaker Genomics Reach Strategic Collaboration to Promote Technological Innovation and Commercialization of Infectious Disease Detection Products

Hugo Biotech and Watchmaker Genomics signed a strategic cooperation agreement in Johannesburg, South Africa, to collaborate on the development of more sensitive, easy-to-use, and lower-cost infectious disease testing products by integrating their respective R&D strengths, with the aim of helping healthcare organizations improve their ability to prevent and control infectious and contagious diseases globally. 

Pluslife and Gates Foundation Sign Collaborative Sexually Transmitted Infections (STI) Program

Pluslife and the Bill & Melinda Gates Foundation recently signed a cooperation agreement on the ‘Sexually Transmitted Infections (STI) Program’ to reduce the burden of STIs in low- and middle-income countries. In the future, the company will continue to invest in the global promotion and application of its products to provide more accurate, affordable and easy-to-use diagnostic tools for low- and middle-income countries.